Prediction markets sue Kentucky over 14.25% tax
Kalshi, Crypto.com, Polymarket and other prediction market platforms have jointly filed a lawsuit in Kentucky state court to block a new 14.25% tax on transaction fees.
Kalshi, Crypto.com, Polymarket and other prediction market platforms have jointly filed a lawsuit in Kentucky state court to block a new 14.25% tax on transaction fees.
SpaceX-linked derivative products have generated more than US$9 billion in total trading volume since their launch in May, as crypto traders rushed to gain synthetic exposure to the company’s market debut.
Bitcoin’s latest mining difficulty adjustment delivered a sharp 10.09% cut, marking one of the largest single downward moves recorded in the network’s history.
Binance Wallet’s SpaceX IPO subscription vehicle attracted $557m from 27,689 wallet addresses, showing strong demand for crypto-based access to private market exposure.
Disc Medicine (NASDAQ:IRON) disclosed positive, updated clinical data across its core hematology pipeline during the 2026 European Hematology Association (EHA) Annual Meeting in Stockholm, Sweden.
Gilead Sciences (NASDAQ:GILD) announced the deployment of an initial emergency donation of more than 2,000 vials of its intravenous antiviral therapy, remdesivir, to the Republic of Uganda.
Triple Flag Precious Metals (NYSE:TFPM) announced that its wholly owned subsidiary, Triple Flag International, has entered into a definitive agreement to acquire a gold stream on the producing Ravenswood Gold Mine in Queensland, Australia.
Cogent Biosciences (NASDAQ:COGT) unveiled highly supportive preclinical findings for its novel small molecule therapeutic candidate, CGT1145, at the 2026 European Hematology Association (EHA) Congress in Stockholm, Sweden.
UniFirst (NYSE:UNF) shareholders voted decisively to approve the company’s pending acquisition by Cintas (NASDAQ:CTAS) during a special meeting.
Cogent Biosciences (NASDAQ:COGT) announced detailed clinical results from its registration-directed APEX trial evaluating its investigational precision therapy, bezuclastinib, in patients with advanced systemic mastocytosis (AdvSM).
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas